STOCK TITAN
  1. Home
  2. News
  3. ATR

Aptargroup - ATR STOCK NEWS

Welcome to our dedicated page for Aptargroup news (Ticker: ATR), a resource for investors and traders seeking the latest updates and insights on Aptargroup stock.

AptarGroup, Inc. (ATR) is a global leader in providing a broad range of innovative dispensing systems for various markets, including beauty, personal care, home care, prescription drug, consumer health care, injectables, food, and beverage. Headquartered in Crystal Lake, Illinois, AptarGroup leverages its extensive manufacturing facilities across North America, Europe, Asia, and South America to serve customers worldwide.

Aptar's product portfolio includes aerosol valves, pumps, closures, and elastomer packaging components. The company operates through three primary business segments: Pharma, Beauty, and Closures. The Pharma division, which is the most significant contributor, is responsible for over two-thirds of the group's profits. The Beauty and Closures segments also play crucial roles in the company’s overall market strategy and revenue generation.

With the majority of its annual net sales stemming from Europe (50%) and the United States (33%), AptarGroup has been focusing on expanding its market presence in Asia (10%) and Latin America (7%). The company continually invests in research and development to maintain its competitive edge and deliver cutting-edge solutions to its clients.

Recent achievements for AptarGroup include strategic partnerships and product innovations that align with their commitment to sustainability and consumer satisfaction. The company continues to develop new dispensing technologies that are both eco-friendly and efficient, addressing the growing demand for sustainable packaging solutions.

For more detailed information about their products and services, visit their official website at www.aptar.com. Stay updated with AptarGroup’s latest developments and financial performance by following their news releases.

News

Aptar Declares Quarterly Dividend

Rhea-AI Summary
AptarGroup, Inc. (NYSE: ATR) announces a quarterly cash dividend of $0.41 per share and a conference call to discuss first quarter results for 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.39%
Tags
dividends
-
News

Aptar Named a CDP Supplier Engagement Leader for the Fourth Consecutive Year

Rhea-AI Summary
AptarGroup, Inc. (NYSE: ATR) has been recognized for its emissions reductions efforts and named to the CDP Supplier Engagement Leaderboard for the fourth consecutive year. Aptar received an 'A' supplier engagement rating, surpassing the global and sector averages. The company collaborates with suppliers to reduce emissions and promote sustainability, with a focus on environmentally conscious supply chain practices.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.84%
Tags
none
-
News

Aptar Named One of Barron’s 100 Most Sustainable U.S. Companies for the Sixth Consecutive Year

Rhea-AI Summary
AptarGroup, Inc. (NYSE: ATR) has been named one of Barron’s 100 Most Sustainable U.S. Companies for the sixth consecutive year, ranking 29th for 2024. The company's commitment to sustainability is evident through various achievements and recognitions, including a Platinum level rating from EcoVadis, significant progress in emissions reduction, and eco-design initiatives.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.12%
Tags
none
News

Aptar Signs Enterprise Agreement with Biogen to Operate and Develop Digital Health Solutions

Rhea-AI Summary
Aptar Digital Health, a part of AptarGroup, Inc., has entered into an enterprise agreement with Biogen Inc. to develop digital health solutions for neurological and rare diseases globally. The collaboration will cover several indications in neurology and immunology across 15 countries, focusing on providing advanced digital solutions for disease management.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.18%
Tags
none
-
News

Aptar Reports Fourth Quarter and Annual 2023 Results

Rhea-AI Summary
AptarGroup, Inc. (NYSE:ATR) reported strong fourth quarter operational results, with a 5% increase in sales and a 6% increase in net income. The company achieved double-digit growth in its proprietary drug delivery systems and fragrance dispensing technologies. The Pharma segment had an exceptional year with over 20% core sales growth in the fourth quarter, while the beauty dispensing solutions in fragrance also delivered double-digit core sales growth for 2023. The company's focus on cost management and operational leverage yielded margin expansion for each segment compared to the prior year. Tanda, President and CEO, expressed optimism for continued solid growth in 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.18%
Tags
none
-
News

Aptar Named One of America’s Most Responsible Companies by Newsweek for the Fifth Consecutive Year

Rhea-AI Summary
AptarGroup, Inc. (NYSE: ATR) has been named one of America’s Most Responsible Companies 2024 by Newsweek for the fifth consecutive year, ranking number 29 out of 600 U.S. companies and first in its industry category. The company's focus on sustainability, renewable energy, and innovative, sustainable products has earned it recognition by Forbes and 3BL Media as well. Aptar publishes an annual Sustainability Report and GRI Index to record and highlight its sustainability efforts.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.8%
Tags
none
News

Aptar Declares Quarterly Dividend and Announces 2024 Annual Meeting Details

Rhea-AI Summary
AptarGroup, Inc. (NYSE: ATR) has declared a quarterly cash dividend of $0.41 per share, with a payment date of February 22, 2024. The company will hold a conference call on February 9, 2024, to discuss its fourth quarter and year-end results for 2023. Additionally, the 2024 Annual Meeting of Stockholders will be held virtually on May 1, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.29%
Tags
dividends
-
News

Aptar to Present at 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024

Rhea-AI Summary
AptarGroup, Inc. (NYSE: ATR) to participate in the 42nd Annual J.P. Morgan Healthcare Conference. Stephan Tanda, President and CEO, to present at 1:30 p.m. Eastern Standard Time. Bob Kuhn, Executive Vice President and CFO, and Gael Touya, President Aptar Pharma, will also be available. Presentation will be available on the Investors page at www.aptar.com.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.02%
Tags
conferences
-
News

Aptar Announces 2024 Quarterly Conference Call Dates

Rhea-AI Summary
AptarGroup, Inc. (NYSE: ATR) announces dates and times of quarterly conference calls for 2024, including 4th Quarter and Annual 2023 Results on February 8, 2024, 1st Quarter 2024 Results on April 25, 2024, 2nd Quarter 2024 Results on July 25, 2024, and 3rd Quarter 2024 Results on October 24, 2024. Press releases will be issued after the close of trading on the NYSE, with conference calls lasting approximately one hour and available for replay on investors.aptar.com.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.02%
Tags
none
News

Aptar Awarded US FDA Contract to Study Opportunities for Low Global Warming Potential Propellants for Metered Dose Inhalers

Rhea-AI Summary
AptarGroup, Inc. (NYSE: ATR) announces a contract with the FDA to study low Global Warming Potential propellant metered dose inhalers, supporting ongoing FDA efforts to provide guidance on the regulatory framework. The contracted work is valued at up to approximately $6 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.25%
Tags
none

FAQ

What is the current stock price of Aptargroup (ATR)?

The current stock price of Aptargroup (ATR) is $146.34 as of February 21, 2025.

What is the market cap of Aptargroup (ATR)?

The market cap of Aptargroup (ATR) is approximately 9.7B.

What products does AptarGroup manufacture?

AptarGroup manufactures aerosol valves, pumps, closures, and elastomer packaging components for various markets, including beauty, personal care, and pharmaceuticals.

Where is AptarGroup headquartered?

AptarGroup is headquartered in Crystal Lake, Illinois.

In which markets does AptarGroup operate?

AptarGroup operates in the beauty, personal care, home care, prescription drug, consumer healthcare, injectables, food, and beverage markets.

What are the main business segments of AptarGroup?

AptarGroup operates through three main business segments: Pharma, Beauty, and Closures.

Where does AptarGroup generate most of its sales?

AptarGroup generates most of its sales from Europe (50%) and the United States (33%).

What percentage of AptarGroup's profits come from the Pharma division?

The Pharma division generates over two-thirds of AptarGroup's profits.

Is AptarGroup expanding in any specific regions?

Yes, AptarGroup is focusing on increasing its presence in Asia (10%) and Latin America (7%).

How does AptarGroup contribute to sustainability?

AptarGroup invests in developing eco-friendly and efficient dispensing technologies to meet the increasing demand for sustainable packaging solutions.

How can I stay updated with AptarGroup's latest news?

You can stay updated with AptarGroup's latest news by following their news releases or visiting their official website at www.aptar.com.
Stock ATR logo
Aptargroup

NYSE:ATR

ATR Rankings

#rank Ranked by Market Cap
#rank Ranked by Dividends

ATR Stock Data

9.74B
65.94M
0.56%
92.61%
0.91%
Medical Instruments & Supplies
Plastics Products, Nec
Link
United States
CRYSTAL LAKE